Generis, creator of the cloud data, content, and business process management platform CARA, announces that pharma& has selected the CARA™ Life Sciences Platform as the basis for its Regulatory, Quality and Legal Management System.
pharma& is a rapidly growing, privately-owned pharmaceutical company based in Vienna, Austria, providing specialty care products. pharma&’s goal is to secure sustainable product availability in markets around the world through affiliated companies, and partnerships.
With unprecedented growth in recent years, pharma& will use Generis’ single platform software solution to assure more effective documentation of many of their internal processes and create previously unestablished synergies within its departments, affiliates and partners.
By following this ‘Greenfield’ approach, the CARA Life Sciences Platform will act as one of the cornerstones of the organisation’s IT infrastructure, and as the framework for wider digital transformation initiatives within the company.
With Generis’ technology, pharma& can remain ahead of the curve and be ready for changing regulations and requirements around the world. “Generis will support pharma& in increasing its traceability and transparency in its quality management system, which is a standard that is required in the industry.” comments Nikhil Verghese, Quality Manager, pharma&.
The business model offered by Generis is based on the ‘one user, one licence’ concept, which is ideal for rapidly growing companies as the platform is highly scalable. This means that as the company grows further, new processes, apps and users can be added easily to the unified, structured ‘information lake’ generated through the platform’s usage. The CARA Life Sciences Platform offers companies the opportunity to unify their entire IT landscape with its unique ‘information lake’ concept for managing data, documents, and other forms of content. This allows users to input information once and easily re-use it, which reduces duplication of work and allows for greater efficiency across the organisation.
pharma& is a privately owned pharmaceutical company with headquarter in Vienna Austria, aiming to satisfy needs for niche, specialty care products. pharma& has acquired multiple products in various therapeutic areas and has secured patient access and product supply across the entire European Landscape as well as multiple countries around the world.
Generis is a UK-headquartered developer of world-class data, content and business process management for regulated industries globally. 60% of the top 20 life sciences companies rely on Generis’ flagship CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer, and Merck KGaA. Today Generis serves more than 750,000 users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com